Research progress on immune checkpoint inhibitors in intrahepatic cholangiocarcinoma
In summary, ICIs are assuming an increasingly prominent role in the management of ICC. Efforts should be made to improve treatment methods and apply combination therapy strategies to address drug resistance. The combination of multiple treatment methods and ongoing research are crucial for addressing the treatment of ICC.
Authors
- Bingqi Ma (ORCID: https://orcid.org/0000-0001-9314-6559)
- Lin Zhang (ORCID: https://orcid.org/0000-0002-3767-0249)
- Zheng Qin Yin (ORCID: https://orcid.org/0000-0002-4253-7485)
- Jiayuan Li (ORCID: https://orcid.org/0000-0002-2920-1637)
- Haiyang Tan
Institutions
- Weifang Medical University (CN)
- Second Hospital of Shandong University (CN)
- Second Affiliated Hospital of Shandong University of TCM (CN)
Publication Details
- Journal
- Annals of Medicine
- Published
- 2025-11-14
- DOI
- https://doi.org/10.1080/07853890.2025.2584667
- Primary Topic
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00